论文部分内容阅读
AIM:To investigate the synergistic effect of oxymatrine (OM) and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cell lines SGC-7901,MKN-45,MKN-74.METHODS:Human gastric cancer lines SGC-7901,MKN-45,MKN-74 were treated with OM in the absence and presence of NM-3. The inhibitory rates were detected by MTT assay. Synergistic effect of OM and NM-3 on the growth of survivin,bcl-2,bax and p53 in SGC-7901 cells were examined by semiquantitative RT-PCR and West blotting,and their growth inhibitory effects were also observed on SGC-7901 tumor xenograft in nude mice.RESULTS:OM combined with NM-3 exhibited a synergistic inhibitory effect on the growth of SGC-7901,MKN-45 and MKN-74 cells in a time-dependent manner. Twenty-four hours after treatment with OM,NM-3 alone and their combination,mRNA expression of survivin and bcl-2 in SGC-7901 cells decreased,p53 mRNA expression increased. OM (4 g/L) combined with NM-3 significantly increased the expression of p53 mRNA and decreased the expression of survivin and bcl-2 compared with either agent alone (193% ± 34% vs 129% ± 12%; 44% ± 18% vs 92% ± 18%; 36 ± 17% vs 93% ± 23%, P＜0.05). West blotting showed that the synergistic effect of OM and NM-3 on protein translation of survivin, bcl-2 and p53 was in accordance with their mRNAs. Furthermore, OM/NM-3 combination obviously exhibited antitumor growth effect in xenografted human gastric cancer cells SGC-7901 compared with either agent alone.CONCLUSION:OM combined with NM-3 has synergistic inhibitory effects on human gastric cancer cells in vitroand can suppress the growth of xenografted human gastric cancer cells SGC-7901 in vivo.